logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q1 adjusted earnings Beat Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$105 million in Q1 vs. $1055 million in the same period last year.
-EPS: -$0.10 in Q1 vs. $1.03 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $654 million or $0.60 per share for the period.
-Analysts projected $0.58 per share
-Revenue: $4.30 billion in Q1 vs. $5.07 billion in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT